← Back to Search

Other

Mango for Prediabetes

N/A
Recruiting
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights

Study Summary

This trial will study the effects of mango consumption on blood sugar levels, heart health, and body composition in overweight and obese people with prediabetes.

Who is the study for?
This trial is for overweight or obese adults with prediabetes, having a BMI between 18.5 to 34.9 and HbA1c levels of 5.7-6.4%. Participants should not have chronic diseases like cancer, uncontrolled high blood pressure, consume excess alcohol, smoke heavily, be on certain supplements or medications, or have had significant weight changes recently.Check my eligibility
What is being tested?
The study investigates the impact of eating mangoes on blood sugar control, heart health, and body composition in individuals with prediabetes compared to a placebo group that does not receive mangoes.See study design
What are the potential side effects?
While the study primarily involves consuming mangoes which are generally safe, potential side effects may include digestive discomfort or allergic reactions in those who might be sensitive to mangoes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effect of mango consumption on glycemic control evaluated by HOMA-IR
Effect of mango consumption on glycemic control evaluated by HOMA-β
Effect of mango consumption on glycemic control evaluated by Insulin
+2 more
Secondary outcome measures
Atherogenic risk ratio (TC/HDL-C, LDLC/HDL-C, HDL-C/LDL-C)
Effect of mango consumption on anthropometric measure WC/HC ratio
Effect of mango consumption on anthropometric measure of HC
+11 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Mango SupplementExperimental Treatment1 Intervention
Participants will consume 120g of fresh mango per day for 24 weeks
Group II: Placebo Matched SupplementPlacebo Group1 Intervention
Participants will consume 200g isocaloric granola bar per day for 24 weeks

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor
198 Previous Clinical Trials
30,646 Total Patients Enrolled
National Mango BoardOTHER
6 Previous Clinical Trials
277 Total Patients Enrolled

Media Library

Mango (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05571800 — N/A
Prediabetes Research Study Groups: Mango Supplement, Placebo Matched Supplement
Prediabetes Clinical Trial 2023: Mango Highlights & Side Effects. Trial Name: NCT05571800 — N/A
Mango (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05571800 — N/A
Prediabetes Patient Testimony for trial: Trial Name: NCT05571800 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What hoped-for outcomes are being sought through this experiment?

"This 3-year trial aims to investigate the influence of mango consumption on glycemic control that will be evaluated using HOMA-IR. Additionally, biomarkers of inflammation (C-reactive protein), lean mass (measured via bioimpedance spectroscopy), and hip circumference (Gulick fiberglass measuring tape with a tension handle) are secondary outcomes being assessed."

Answered by AI

Does this medical research have an age limit for prospective participants?

"According to the outlined conditions, persons eligible for enrolment must be between 50 and 70 years of age."

Answered by AI

Who is eligible to be part of this trial's cohort?

"This research program seeks to recruit 40 pre-diabetic individuals, aged between 50 and 70 years old. In order to qualify for participation in the study, patients must have no serious chronic illnesses (e.g., cancer) while also falling within certain body mass index parameters and glycemic thresholds. Specifically, a BMI of 18.5-34.9 kg/m2 as well as a wHbA1c value ranging from 100mg/dl - 125 mg/dl and an HbA1C percentage of 5.7%-6.4% are needed for consideration into the trial's cohort groupings."

Answered by AI

Does this research endeavor currently accept volunteers?

"According to clinicaltrials.gov, this trial is presently open for enrolment and has been since May 1st 2022 (last updated October 6th 2022)."

Answered by AI

How many persons have been recruited to join this experiment?

"Indeed, the clinical data hosted on clinicaltrials.gov reveals that enrollment for this medical study is still ongoing since it was first published on May 1st 2022 and last updated on October 6th 2022. 40 individuals are needed to join at one particular site."

Answered by AI

Who else is applying?

What state do they live in?
California
Oregon
Florida
What site did they apply to?
Florida State University
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
3+
1
0

Why did patients apply to this trial?

Unable to lose weight on my own. I do not want to convert to diabetes. Catch problems before they get advanced.
PatientReceived 1 prior treatment
Thought it would be interesting, plus improve my health. I’ve tried met for main and I am not able to handle the side effects.
PatientReceived 1 prior treatment

How responsive is this trial?

Typically responds via
Email
Phone Call
Most responsive sites:
  1. Florida State University: < 24 hours
Average response time
  • < 1 Day
~14 spots leftby Apr 2025